Global Life Science Ventures Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

Investment experience to support growth opportunities

successful exits and M&A transactions
board seat representations

Since its foundation in 1996, GLSV has successfully established an attractive portfolio of life science companies. The company's first fund, GLSV I, was invested in 18 ventures. The development of this fund was validated by successful exits and merger & acquisition transactions and also included a number of board seat representations, several of which were at chairman level.

With the successful completion of its second fund in 2002, GLSV has entered a new period of growth opening up further opportunities to support the development of businesses. The second fund is being used to finance promising companies active across the life science industry. More details on the companies we have financed to date are available via the following link: Portfolio companies.

The latest news on our investments is available in our News & Events section.